Description
Chimeric antibody 20E5 specifically binds to the extracellular domain of human CD134 and is useful for cancer treatment.
Target
TNFRSF4
Target Alias Names
OX40, ACT35, CD134, IMD16, TXGP1L
Isotypes/Mimetics
Chimeric lgG4, κ
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression